MedTrace Logo

Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients

NCT03289364 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-04-28

Study results available
· View outcomes & findings →

Summary

The goal of this study is to estimate the efficacy of Penguin cold caps in preventing or reducing hair loss in patients receiving (neo)adjuvant chemotherapy (one of four common regimens) for early stage breast cancer.

Conditions

Interventions

DEVICE

Penguin Cold Caps

Patients will wear Penguin Cold Cap scalp cooling device prior to each chemotherapy administration, during administration, and for four hours following administration.

Sponsors & Collaborators

  • Medical Specialties of California

    collaborator UNKNOWN

  • Providence Health & Services

    lead OTHER

Principal Investigators

  • David Page, MD · Providence Health & Services

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-24
Primary Completion
2021-08-19
Completion
2021-08-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03289364 on ClinicalTrials.gov